JP Patent

JP7727652B2 — 少なくとも２つの液体組成物のエアロゾル送達

Assigned to Invox Belgium NV · Expires 2025-08-21 · 1y expired

What this patent protects

Patent listed against Remodulin.

Drugs covered by this patent

Remodulin (TREPROSTINIL) · United Therap

Patent Metadata

Patent number: JP7727652B2
Jurisdiction: JP
Classification: —
Expires: 2025-08-21
Drug substance claim: No
Drug product claim: No
Assignee: Invox Belgium NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.